Sanofi News Headlines

SNY 
$52.79
*  
0.50
0.94%
Get SNY Alerts
*Delayed - data as of Aug. 20, 2014  -  Find a broker to begin trading SNY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

MARKET SNAPSHOT: U.S. Stocks: Futures Up After Fischer Says Global Recovery Disappointing
8/11/2014 5:50:00 AM - Dow Jones Business News

European Stocks Seen Rising As Risk Appetite Improves
8/11/2014 2:17:00 AM - RTT News

Sanofi, MannKind in Global Pact for Inhaled Insulin
8/11/2014 1:58:00 AM - Dow Jones Business News

Sanofi, MannKind To Launch Afrezza In U.S. In Q1, 2015 - Quick Facts
8/11/2014 1:28:00 AM - RTT News

Alnylam Pharmaceuticals Has Plenty On Its Plate
8/9/2014 10:36:00 AM - Seeking Alpha

VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog
8/8/2014 11:00:00 AM - Zacks.com

The Case That Regeneron May Be Significantly Undervalued
8/8/2014 10:42:00 AM - Seeking Alpha

InterMune Q2 Loss Wider than Expected, Expense Guidance Up - Analyst Blog
8/7/2014 2:50:00 PM - Zacks.com

Sanofi: Confronting Lantus Patent Expiry With More Efficient Successor Toujeo
8/7/2014 11:59:00 AM - Seeking Alpha

SNY Makes Notable Cross Below Critical Moving Average
8/7/2014 11:49:59 AM - BNK Invest

Synta Posts Narrower Q2 Loss; Names Anne Whitaker CEO
8/6/2014 1:03:00 PM - RTT News

Regeneron Misses on Earnings in Q2, Eylea Drives Sales Beat - Analyst Blog
8/5/2014 3:02:00 PM - Zacks.com

Regeneron Pharma Q2 Profit Increases - Quick Facts
8/5/2014 6:42:00 AM - RTT News

ImmunoGen Q4 Loss Narrower than Expected, Provides Guidance - Analyst Blog
8/4/2014 2:50:00 PM - Zacks.com

Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential
8/4/2014 7:36:00 AM - Seeking Alpha

Update: Sanofi Should Finally Start Growing Again
8/3/2014 9:23:00 AM - Seeking Alpha

BioMarin Q2 Loss Narrower than Expected, Revenue Guidance Up - Analyst Blog
7/31/2014 5:00:00 PM - Zacks.com

German Stocks Hammered As Most European Markets Tumble
7/31/2014 11:59:00 AM - RTT News

3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP
7/31/2014 11:44:13 AM - Zacks.com

European Stocks Fall For Second Day
7/31/2014 7:04:00 AM - RTT News

Wall Street's Worries Return With Force
7/31/2014 6:30:00 AM - RTT News

Sanofi Q2 Profit Surges, Lifts FY Earnings View
7/31/2014 6:06:00 AM - RTT News

SANOFI Posts Higher Q2 Profit; Adjusts 2014 Outlook - Quick Facts
7/31/2014 1:55:00 AM - RTT News

BioMarin Sells Priority Review Voucher To Regeneron
7/30/2014 5:42:00 PM - Dow Jones Business News

Regeneron Pharmaceuticals Inc. (REGN) Is Surging On Phase 3 Study Results
7/30/2014 9:32:00 AM - RTT News